Statement of Changes in Beneficial Ownership (4)
FORM 4 [ ]Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.SeeInstruction 1(b). | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL OMB Number:3235-0287 Estimated average burden hours per response...0.5 |
| 1. Name and Address of Reporting Person*KATZAROFF JAMES C | 2. Issuer NameandTicker or Trading SymbolADVANCED MEDICAL ISOTOPE Corp[ADMD] | 5. Relationship of Reporting Person(s) to Issuer(Check all applicable)__X__ Director__X__ 10% Owner __X__ Officer (give title below)_____ Other (specify below) CEO |
| 3. Date of Earliest Transaction(MM/DD/YYYY) | ||
| 4. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
| 1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any | 3. Trans. Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 12/17/2014 | A | 1673870 | A | (1) | 4339704 | D | |||
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
| 1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Convertible Note | $.0005 | 12/17/2014 | A | $21300 | 12/17/2014 | 12/17/2015 | Common Stock | 42600000(2) | (1) | 21300 | D | ||||
| Reporting Owners | |||||
| Reporting Owner Name / Address | |||||
| Director | 10% Owner | Officer | Other | ||
| KATZAROFF JAMES C 190808 EAST 45TH KENNEWICK,WA99337 | X | X | CEO | ||
| Signatures | ||
| James C. Katzaroff | 12/19/2014 | |
| **Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
| * | If the form is filed by more than one reporting person,seeInstruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations.See18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient,seeInstruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |
Vivos (QB) (USOTC:RDGL)
Historical Stock Chart
From May 2024 to Jun 2024
Vivos (QB) (USOTC:RDGL)
Historical Stock Chart
From Jun 2023 to Jun 2024
 | {{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}} |
Loading Messages....
Advanced Medical Isotope Corp News
Loading Messages....
`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `
`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `
FEATURED
•{{ article.source }} • {{ article.date}} {{article.time}}
`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjIwMg==","timestamp":1718341620,"date":"Fri Jun 14, 2024 ","time":"1:07 AM (8 hours ago)","isPromoted":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/93983286\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717525730,"date":"Tue Jun 04, 2024 ","time":"2:28 PM (1 week ago)","full_date":"June 4, 2024 2:28 PM","post_time":"June 04 2024","article_id":93983286,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/93819829\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715290231,"date":"Thu May 09, 2024 ","time":"5:30 PM (1 month ago)","full_date":"May 9, 2024 5:30 PM","post_time":"May 09 2024","article_id":93819829,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92897207\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1703713248,"date":"Wed Dec 27, 2023 ","time":"4:40 PM (6 months ago)","full_date":"December 27, 2023 4:40 PM","post_time":"December 27 2023","article_id":92897207,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form QUALIF - Notice of Qualification [Regulation A]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92749236\/form-qualif-notice-of-qualification-regulation","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1701926110,"date":"Thu Dec 07, 2023 ","time":"12:15 AM (6 months ago)","full_date":"December 7, 2023 12:15 AM","post_time":"December 07 2023","article_id":92749236,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 1-A POS -","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92661434\/form-1-a-pos","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1701124152,"date":"Mon Nov 27, 2023 ","time":"5:29 PM (7 months ago)","full_date":"November 27, 2023 5:29 PM","post_time":"November 27 2023","article_id":92661434,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92472258\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1699288126,"date":"Mon Nov 06, 2023 ","time":"11:28 AM (7 months ago)","full_date":"November 6, 2023 11:28 AM","post_time":"November 06 2023","article_id":92472258,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 1-A POS -","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92460304\/form-1-a-pos","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1699045400,"date":"Fri Nov 03, 2023 ","time":"5:03 PM (7 months ago)","full_date":"November 3, 2023 5:03 PM","post_time":"November 03 2023","article_id":92460304,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92318891\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1697732314,"date":"Thu Oct 19, 2023 ","time":"12:18 PM (8 months ago)","full_date":"October 19, 2023 12:18 PM","post_time":"October 19 2023","article_id":92318891,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92248052\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1697020438,"date":"Wed Oct 11, 2023 ","time":"6:33 AM (8 months ago)","full_date":"October 11, 2023 6:33 AM","post_time":"October 11 2023","article_id":92248052,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 1-A POS -","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92240243\/form-1-a-pos","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1696953936,"date":"Tue Oct 10, 2023 ","time":"12:05 PM (8 months ago)","full_date":"October 10, 2023 12:05 PM","post_time":"October 10 2023","article_id":92240243,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/91739759\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1691176941,"date":"Fri Aug 04, 2023 ","time":"3:22 PM (10 months ago)","full_date":"August 4, 2023 3:22 PM","post_time":"August 04 2023","article_id":91739759,"source_id":"edgar2","media_url":null,"press_release":true}],"All News": [{"headline":"Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjIwMg==","timestamp":1718341620,"date":"Fri Jun 14, 2024 ","time":"1:07 AM (8 hours ago)","isPromoted":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/93983286\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717525730,"date":"Tue Jun 04, 2024 ","time":"2:28 PM (1 week ago)","full_date":"June 4, 2024 2:28 PM","post_time":"June 04 2024","article_id":93983286,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/93819829\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1715290231,"date":"Thu May 09, 2024 ","time":"5:30 PM (1 month ago)","full_date":"May 9, 2024 5:30 PM","post_time":"May 09 2024","article_id":93819829,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92897207\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1703713248,"date":"Wed Dec 27, 2023 ","time":"4:40 PM (6 months ago)","full_date":"December 27, 2023 4:40 PM","post_time":"December 27 2023","article_id":92897207,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form QUALIF - Notice of Qualification [Regulation A]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92749236\/form-qualif-notice-of-qualification-regulation","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1701926110,"date":"Thu Dec 07, 2023 ","time":"12:15 AM (6 months ago)","full_date":"December 7, 2023 12:15 AM","post_time":"December 07 2023","article_id":92749236,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 1-A POS -","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92661434\/form-1-a-pos","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1701124152,"date":"Mon Nov 27, 2023 ","time":"5:29 PM (7 months ago)","full_date":"November 27, 2023 5:29 PM","post_time":"November 27 2023","article_id":92661434,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92472258\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1699288126,"date":"Mon Nov 06, 2023 ","time":"11:28 AM (7 months ago)","full_date":"November 6, 2023 11:28 AM","post_time":"November 06 2023","article_id":92472258,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 1-A POS -","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92460304\/form-1-a-pos","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1699045400,"date":"Fri Nov 03, 2023 ","time":"5:03 PM (7 months ago)","full_date":"November 3, 2023 5:03 PM","post_time":"November 03 2023","article_id":92460304,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92318891\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1697732314,"date":"Thu Oct 19, 2023 ","time":"12:18 PM (8 months ago)","full_date":"October 19, 2023 12:18 PM","post_time":"October 19 2023","article_id":92318891,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92248052\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1697020438,"date":"Wed Oct 11, 2023 ","time":"6:33 AM (8 months ago)","full_date":"October 11, 2023 6:33 AM","post_time":"October 11 2023","article_id":92248052,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 1-A POS -","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/92240243\/form-1-a-pos","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1696953936,"date":"Tue Oct 10, 2023 ","time":"12:05 PM (8 months ago)","full_date":"October 10, 2023 12:05 PM","post_time":"October 10 2023","article_id":92240243,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/USOTC\/vivos-qb-RDGL\/stock-news\/91739759\/form-10-q-quarterly-report-sections-13-or-15d","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1691176941,"date":"Fri Aug 04, 2023 ","time":"3:22 PM (10 months ago)","full_date":"August 4, 2023 3:22 PM","post_time":"August 04 2023","article_id":91739759,"source_id":"edgar2","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});
More Advanced Medical Isotope Corp News Articles
